Add time:08/27/2019         Source:sciencedirect.com

Herein we disclose SAR studies of a series of dimethylamino pyrrolidines which we recently reported as novel inhibitors of the PRC2 complex through disruption of EED/H3K27me3 binding. Modification of the indole and benzyl moieties of screening hit 1 provided analogs with substantially improved binding and cellular activities. This work culminated in the identification of compound 2, our nanomolar proof-of-concept (PoC) inhibitor which provided on-target tumor growth inhibition in a mouse xenograft model. X-ray crystal structures of several inhibitors bound in the EED active-site are also discussed.

We also recommend Trading Suppliers and Manufacturers of (3S)-(-)-3-(DIMETHYLAMINO)PYRROLIDINE (cas 132883-44-4). Pls Click Website Link as below: cas 132883-44-4 suppliers